Sinclair Pharma PLC (LSE:SPH) - Overview

Stock Report

Sinclair Pharma PLC SPH

Last Price
GBX30.75

Day Change
-0.50|-1.60%

As of 02/12/2016
16:30:40 GMT | GBX
Minimum 15 Minutes Delay.

Last Close31.25p
Day Range30.16 - 31.50
Mkt Cap154.40Mil
52-Wk Range26.00 - 61.33
Yield %0.00
ISINGB0033856740
Volume301,001
P/E-29.15
P/S2.01
P/CF35.92

Share Price

Total Returns 02/12/2016

 Chg (%)  
More ...
Sinclair Pharma PLC5.13 
FTSE 100 TR GBP-1.21
 
Financials
201320142015
More ...
Income Statement
Turnover55.3863.5675.89
Operating Profit-15.33-1.794.54
Net Profit-15.85-4.09-7.21
Reported EPS-3.70-0.90-1.50
Balance Sheet
Current Assets29.8554.6747.95
Non Current Assets126.17246.95237.47
Total Assets156.02302.72285.42
Current Liabilities24.0342.8846.75
Total Liabilities45.48184.80179.85
Total Equity110.54117.92105.57
Cash Flow
Operating Cash Flow2.58-4.369.98
Net Change in Cash1.0312.68-5.09
Broker Forecasts
Year EndingPre-taxEPSEPSgP/EPEGDPSYld %
More ...
'Broker Forecasts' provides consensus figures based on several brokers' views
2016-17.13-3.09--9.95---
2017-7.55-1.51--20.32---
Director Dealings
TradedActionNotifierPriceAmountValue
More ...
04/10/2016PurchaseMr. Jeff Thompson29.13150,00043,688.00
30/09/2016Transfer inMr. Chris Spooner0.001,101,3150.00
27/05/2016PurchaseMr. Jean-Charles Tschudin36.2597,00035,163.00
26/05/2016PurchaseMr. Jean-Charles Tschudin35.503,0231,073.00

Company Profile

Sinclair Pharma PLC is a specialty pharmaceutical company focused on Dermatology, in particular - Aesthetics, Wound care, and Skin care.
 

Sector

Drug Manufacturers - Specialty & Generic

Market Position

748 of 1865 Companies

Index

FTSE AIM 100 ,FTSE AIM All Share

Outlook

(21/09/2016) "We are confident in our 2016 outlook"

Next Event 23/12/2016

Next annual report due
Ratios
CompSecMkt
More ...
PER (E)-20.3213.1416.27
Div Yld (E)0.004.184.36
PEG (E)0.000.360.00
ROCE0.55206.9680.66
Op Mrgn-0.35-17.09-14.86
EPS Grwth0.009.6525.03
Dividends
PreviousLatest
More ...
Record Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00

Broker Sentiment

Strong Buy0
Buy3
Hold0
Sell0
Strong Sell0
  • Strong Sell
  • Strong Buy
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
More ...
Disclaimer
Directors
More ...
ChairmanMr. Grahame Cook
Chief Executive OfficerMr. Chris Spooner
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at Trafford House, Chester Road, Manchester M32 0RS. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2016 Morningstar. All rights reserved.